{
  "timestamp": "2026-01-05T07:39:59.790707",
  "agent_id": "medication_management",
  "phase": "complete",
  "input_data": null,
  "prompt": null,
  "llm_response": null,
  "output_data": {
    "clarification_needed": false,
    "clarification_question": null,
    "suggested_answer": null,
    "medications": [
      {
        "name": "Sertraline",
        "generic_name": "Sertraline",
        "brand_name": "null",
        "strength": "50mg",
        "form": "Tablet",
        "route": "Oral",
        "frequency": "Daily",
        "indication": "*Major Depressive Disorder* (Inferred)",
        "response": "Minimal response after 4 weeks",
        "adherence": "Good (taking every day)",
        "side_effects": []
      }
    ],
    "changes_made": [
      {
        "medication": "Sertraline",
        "change_type": "Increase Dose",
        "rationale": "Inadequate clinical response (persistent severe depressive symptoms including early morning awakening and passive thoughts of death) to 50mg daily after 4 weeks of treatment."
      }
    ],
    "peer_review_finding": {
      "diagnosis_mapping": "Major Depressive Disorder (MDD) is the most likely proposed diagnosis based on the clinical picture.",
      "medication_match": "**MATCH**. *Sertraline* (SSRI) is standard first-line treatment for MDD. The proposed medication aligns with the presenting symptoms and anticipated diagnosis.",
      "flag": false
    }
  },
  "duration_ms": 5220,
  "error": null
}